BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 36271070)

  • 1. Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study.
    Cui J; Dou X; Sun Y; Yue J
    PeerJ; 2020; 8():e9513. PubMed ID: 32704453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of LGR for distant metastasis-free survival in locally advanced rectal cancer patients.
    Lv M; Wu S; Zhang Z; Zhang Z; Wan J
    Heliyon; 2024 Jun; 10(11):e32045. PubMed ID: 38867999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients with complete pathological response to neoadjuvant chemoradiotherapy for locally advanced rectal cancers: the Indian scenario.
    Sinukumar S; Patil P; Engineer R; Desouza A; Saklani A
    Gastroenterol Res Pract; 2014; 2014():867841. PubMed ID: 25610460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location is an independent predictive factor for distant metastasis and metastatic sites of rectal adenocarcinoma in patients receiving total mesorectal excision.
    Chen CH; Hsieh MC; Hsiao PK; Lin EK; Lu YJ; Wu SY
    J Cancer; 2018; 9(6):950-958. PubMed ID: 29581774
    [No Abstract]   [Full Text] [Related]  

  • 5. Early distant relapse after optimal local control in locally advanced rectal cancer.
    Gallego-Plazas J; Menarguez-Pina F; Martinez-Banaclocha N; Pons-Sanz V; Mingol-Navarro F; Ruiz-Macia JA; Macia-Escalante S
    Int Semin Surg Oncol; 2008 Jul; 5():18. PubMed ID: 18620609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer.
    Bhudia J; Glynne-Jones R
    Curr Treat Options Oncol; 2022 Apr; 23(4):453-473. PubMed ID: 35312962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Liu YP; Sun J; Zheng J
    Discov Oncol; 2022 Oct; 13(1):111. PubMed ID: 36271070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
    Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y
    Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
    Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
    Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.
    Guida AM; Sensi B; Formica V; D'Angelillo RM; Roselli M; Del Vecchio Blanco G; Rossi P; Capolupo GT; Caricato M; Sica GS
    Biol Direct; 2022 Jun; 17(1):16. PubMed ID: 35698084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
    Jin J; Tang Y; Hu C; Jiang LM; Jiang J; Li N; Liu WY; Chen SL; Li S; Lu NN; Cai Y; Li YH; Zhu Y; Cheng GH; Zhang HY; Wang X; Zhu SY; Wang J; Li GF; Yang JL; Zhang K; Chi Y; Yang L; Zhou HT; Zhou AP; Zou SM; Fang H; Wang SL; Zhang HZ; Wang XS; Wei LC; Wang WL; Liu SX; Gao YH; Li YX
    J Clin Oncol; 2022 May; 40(15):1681-1692. PubMed ID: 35263150
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.